Rumors have emerged throughout the astronautical community that the space agency are studying the prospective benefits of 2-CB, a copyright drug , in address the difficulties of deep orbital flight . Preliminary indications suggest the organization is interested in its potential to reduce mental anxiety and enhance team efficiency on future far-rea